D409H GBA1 mutation accelerates the progression of pathology in A53T α-synuclein transgenic mouse model
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-5960
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
D409H GBA1 mutation accelerates the progression of pathology in A53T α-synuclein transgenic mouse model ; volume:6 ; number:1 ; day:27 ; month:4 ; year:2018 ; pages:1-12 ; date:12.2018
Acta Neuropathologica Communications ; 6, Heft 1 (27.4.2018), 1-12, 12.2018
- Creator
-
Kim, Donghoon
- Contributor
-
Hwang, Heehong
Choi, Seulah
Kwon, Sang Ho
Lee, Suhyun
Park, Jae Hong
Kim, SangMin
Ko, Han Seok
SpringerLink (Online service)
- DOI
-
10.1186/s40478-018-0538-9
- URN
-
urn:nbn:de:101:1-2018070116082750042837
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kim, Donghoon
- Hwang, Heehong
- Choi, Seulah
- Kwon, Sang Ho
- Lee, Suhyun
- Park, Jae Hong
- Kim, SangMin
- Ko, Han Seok
- SpringerLink (Online service)
Other Objects (12)
Induction of CNS α-synuclein pathology by fibrillar and non-amyloidogenic recombinant α-synuclein
Alcohol consumers with liver pathology rarely display α-synuclein pathology
α-Synuclein serine129 phosphorylation – the physiology of pathology
Comparative analyses of the in vivo induction and transmission of α-synuclein pathology in transgenic mice by MSA brain lysate and recombinant α-synuclein fibrils
Studies of lipopolysaccharide effects on the induction of α-synuclein pathology by exogenous fibrils in transgenic mice
LRRK2 inhibition does not impart protection from α-synuclein pathology and neuron death in non-transgenic mice
Lysosomal dysfunction in α-synuclein pathology: molecular mechanisms and therapeutic strategies
ASC specks exacerbate α‑synuclein pathology via amplifying NLRP3 inflammasome activities
Carboxyl truncation of α-synuclein occurs early and is influenced by human APOE genotype in transgenic mouse models of α-synuclein pathogenesis
![The relationship between α-synuclein [alpha-synuclein] and the proteasome and its role in Parkinson's pathology](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
The relationship between α-synuclein [alpha-synuclein] and the proteasome and its role in Parkinson's pathology
Granulovacuolar degeneration bodies are independently induced by tau and α-synuclein pathology
Hippocampal subfield vulnerability to α-synuclein pathology precedes neurodegeneration and cognitive dysfunction
Induction of CNS α-synuclein pathology by fibrillar and non-amyloidogenic recombinant α-synuclein
Alcohol consumers with liver pathology rarely display α-synuclein pathology
α-Synuclein serine129 phosphorylation – the physiology of pathology
Comparative analyses of the in vivo induction and transmission of α-synuclein pathology in transgenic mice by MSA brain lysate and recombinant α-synuclein fibrils
Studies of lipopolysaccharide effects on the induction of α-synuclein pathology by exogenous fibrils in transgenic mice
LRRK2 inhibition does not impart protection from α-synuclein pathology and neuron death in non-transgenic mice
Lysosomal dysfunction in α-synuclein pathology: molecular mechanisms and therapeutic strategies
ASC specks exacerbate α‑synuclein pathology via amplifying NLRP3 inflammasome activities
Carboxyl truncation of α-synuclein occurs early and is influenced by human APOE genotype in transgenic mouse models of α-synuclein pathogenesis
The relationship between α-synuclein [alpha-synuclein] and the proteasome and its role in Parkinson's pathology
Granulovacuolar degeneration bodies are independently induced by tau and α-synuclein pathology
Hippocampal subfield vulnerability to α-synuclein pathology precedes neurodegeneration and cognitive dysfunction
Induction of CNS α-synuclein pathology by fibrillar and non-amyloidogenic recombinant α-synuclein
Alcohol consumers with liver pathology rarely display α-synuclein pathology
α-Synuclein serine129 phosphorylation – the physiology of pathology
Comparative analyses of the in vivo induction and transmission of α-synuclein pathology in transgenic mice by MSA brain lysate and recombinant α-synuclein fibrils
Studies of lipopolysaccharide effects on the induction of α-synuclein pathology by exogenous fibrils in transgenic mice
LRRK2 inhibition does not impart protection from α-synuclein pathology and neuron death in non-transgenic mice
Lysosomal dysfunction in α-synuclein pathology: molecular mechanisms and therapeutic strategies
ASC specks exacerbate α‑synuclein pathology via amplifying NLRP3 inflammasome activities
Carboxyl truncation of α-synuclein occurs early and is influenced by human APOE genotype in transgenic mouse models of α-synuclein pathogenesis
The relationship between α-synuclein [alpha-synuclein] and the proteasome and its role in Parkinson's pathology
Granulovacuolar degeneration bodies are independently induced by tau and α-synuclein pathology